Results 241 to 250 of about 249,251 (301)

Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways. [PDF]

open access: yesBiomedicines
Carriera L   +10 more
europepmc   +1 more source

Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay

open access: yesMovement Disorders, EarlyView.
Abstract Background The cerebrospinal fluid alpha‐synuclein seed amplification assay (CSFasynSAA) detects alpha‐synuclein aggregation in over 90% of individuals with sporadic PD (sPD). However, the clinical characteristics of sPD with negative CSFasynSAA remain undefined.
Sarah M. Brooker   +30 more
wiley   +1 more source

The monkeypox virus suppresses autophagy by modulating Rubicon expression. [PDF]

open access: yesCell Death Discov
Refolo G   +8 more
europepmc   +1 more source

Endoscopic small bowel therapies for type 2 diabetes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel   +4 more
wiley   +1 more source

TGF-β Signaling in the Pathophysiology of the Ovary: A Double-Edged Regulator. [PDF]

open access: yesBiomolecules
Bertani N   +11 more
europepmc   +1 more source

LEGAL IMPLICATIONS OF THE ROME II REGULATION FOR PRODUCT LIABILITY DISPUTES IN EUROPE

open access: yes
The Rome II Regulation is a legal framework that pertains to the determination of the applicable law in cases involving non-contractual obligations, which encompasses claims related to product liability. This article undertakes an analysis of the effects of the Rome II Regulation on claims related to product liability within various jurisdictions ...
openaire   +1 more source

Home - About - Disclaimer - Privacy